results for liver cancer were slightly attenuated after additional adjustment for liver enzyme levels and hepatitis b surface antigen status (men: hr, 0.60; p trend < .001; women: hr, 0.46; p trend = .003) and exclusion of the first 10 years of follow-up (men: hr, 0.59; p trend < .001; women: hr, 0.44; p trend < .001).